Table of contents
Rapid sequence induction and intubation
What's new
Added 2023 SCCM, 2022 ESAIC, and 2017 SFAR/SFRL guidelines for rapid sequence induction and intubation.
Guidelines
Key sources
The following summarized guidelines for the management of rapid sequence induction and intubation are prepared by our editorial team based on guidelines from the Society of Critical Care Medicine (SCCM 2023), the European Society of Anaesthesiology and Intensive Care (ESAIC 2022), and the French Society of Anesthesia and Intensive Care (SFAR/SFRL 2017).
1
2
3
Respiratory support
Positioning: as per SCCM 2023 guidelines, consider using the head and torso inclined (semi-Fowler) position during rapid sequence intubation.
C
More topics in this section
Preoxygenation
Medical management
Induction agents
As per SCCM 2023 guidelines:
Administer a sedative-hypnotic induction agent when a neuromuscular-blocking agent is used for intubation.
E
Recognize that there is no difference between etomidate and other induction agents administered for rapid sequence intubation with respect to mortality or the incidence of hypotension or vasopressor use during the peri-intubation period and through hospital discharge.
B
More topics in this section
Neuromuscular blockers
Periprocedural vasopressors
Postprocedural corticosteroids